Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000386179

Medchemexpress LLC LYG-409 | 3053857-55-6 | 98.1% | 515.44 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY170952100MG

Encompass_Preferred

LYG-409 is an orally active degrader of GSPT1. It has demonstrated excellent anti-acute myeloid leukemia and prostate cancer activity in vivo, with Tumor Growth Inhibition (TGI) rates of 94.34% and 104.49%, respectively. In vitro, it inhibits KG-1 cells through the degradation of GSPT1, exhibiting an IC50 of 9.50 nM and a DC50 of 7.87 nM.

  • Orally active GSPT1 degrader.
  • Shows excellent anti-acute myeloid leukemia and prostate cancer effects in vivo.
  • Inhibits KG-1 cells through GSPT1 degradation.
  • For research use only.

Catalog No. 50-003-86179


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.